XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.94

+0.8%

2:40 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ellen M. Martin who wrote (5100)	12/11/1997 11:09:00 PM
From: Robert K.	Read Replies (1) of 17367

Is this kindof like a clue of some sort? In reading the lancet article (thank you cacaito). I found a very interesting tidbit. "autoantibodies to bpi have been detected in patients with vasculitis, inflamatory bowel disease,cyctic fibrosis... suggesting bpi can be a anca antigen. HOWEVER these antibodies seem to be directed against the c-terminal region of bpi and DO NOT react with bpi21" (as per Dunn A-personal communication) (bpi21 is n terminal portion of bpi) So I say that.... Therefore one may infer that if 88% (of a small study) of cf patients have anca to bpi, (or a defect in host defense),than bpi may infer some benefit.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next